-
Ipca Labs evaluates US market for hydroxychloroquine sulphate supply
expresspharma
March 25, 2020
Mumbai based pharmaceutical firm, Ipca Laboratories recently announced that the United States Food and Drug Administration (FDA) has made an exception ...
-
Zydus Cadila launches insomnia drug in the US market
expresspharma
July 25, 2019
The drug will be manufactured at group’s formulations manufacturing facility at SEZ, Ahmedabad
-
Dr Reddy’s launches Tobramycin Inhalation Solutionin US Market
expressbpd
June 27, 2019
Dr Reddy’s Tobramycin Inhalation Solution, USP is available in a 300 mg/5 mL, single-dose Ampule
-
Biocon to soon expand its presence in biosimilars in US market
expressbpd
April 04, 2019
Dr Mazumdar Shaw, CMD, Biocon said that women must be encouraged to become entrepreneurs
-
Strides to launch Potassium Chloride Extended-Release tablets in the US market
expressbpd
April 03, 2019
Product jointly developed with Pharmaceutics International, Inc to be commercialized by Strides in the US market
-
Dr. Reddy's brings Propofol injectable emulsion in US market
biospectrumasia
January 28, 2019
Dr. Reddy’s Propofol Injectable Emulsion, USP is available in 10 mg/mL vials for Single Patient Use Only
-
Sun Pharma recalls about 14k cartons of anaesthesia injection from US market
expressbpd
January 10, 2019
Vecuronium Bromide for injection is used as an adjunct to general anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation and is packaged in a glass vial.
-
GSK Ships 2017-18 Seasonal Influenza Vaccines for US Market
americanpharmaceuticalreview
July 18, 2017
GSK has begun shipping quadrivalent vaccine doses to US healthcare providers, following licensing and lot-release approval from the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research.
-
Aurobindo to expand into EU, US over next three to four years
financialexpress
July 05, 2017
The company looks to launch various new products in the US market
-
Express Scripts says cost of branded drugs in US rose nearly 11 percent last year
firstwordpharma
February 07, 2017
According to a report released by Express Scripts on Monday, the average list price of the most commonly used branded drugs in the US increased nearly 11 percent in 2016.